Skip to content

Johnson & Johnson

NYSE: JNJ · USD

Johnson & Johnson financials

6 charts

Revenue

USD millions

$25,310M
Johnson & Johnson Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$15,239M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$15,081M; −1.0% vs FY 2009 Q2
FY 2009 Q4$16,551M; +9.7% vs FY 2009 Q3
FY 2010 Q1$15,631M; −5.6% vs FY 2009 Q4
FY 2010 Q2$15,330M; −1.9% vs FY 2010 Q1
FY 2010 Q3$14,982M; −2.3% vs FY 2010 Q2
FY 2010 Q4$15,644M; +4.4% vs FY 2010 Q3
FY 2011 Q1$16,173M; +3.4% vs FY 2010 Q4
FY 2011 Q2$16,597M; +2.6% vs FY 2011 Q1
FY 2011 Q3$16,005M; −3.6% vs FY 2011 Q2
FY 2011 Q4$16,255M; +1.6% vs FY 2011 Q3
FY 2012 Q1$16,139M; −0.7% vs FY 2011 Q4
FY 2012 Q2$16,475M; +2.1% vs FY 2012 Q1
FY 2012 Q3$17,052M; +3.5% vs FY 2012 Q2
FY 2012 Q4$17,558M; +3.0% vs FY 2012 Q3
FY 2013 Q1$17,505M; −0.3% vs FY 2012 Q4
FY 2013 Q2$17,877M; +2.1% vs FY 2013 Q1
FY 2013 Q3$17,575M; −1.7% vs FY 2013 Q2
FY 2013 Q4$18,355M; +4.4% vs FY 2013 Q3
FY 2014 Q1$18,115M; −1.3% vs FY 2013 Q4
FY 2014 Q2$19,495M; +7.6% vs FY 2014 Q1
FY 2014 Q3$18,467M; −5.3% vs FY 2014 Q2
FY 2014 Q4$18,254M; −1.2% vs FY 2014 Q3
FY 2015 Q1$17,374M; −4.8% vs FY 2014 Q4
FY 2015 Q2$17,787M; +2.4% vs FY 2015 Q1
FY 2015 Q3$17,102M; −3.9% vs FY 2015 Q2
FY 2015 Q4$17,811M; +4.1% vs FY 2015 Q3
FY 2016 Q1$17,482M; −1.8% vs FY 2015 Q4
FY 2016 Q2$18,482M; +5.7% vs FY 2016 Q1
FY 2016 Q3$17,820M; −3.6% vs FY 2016 Q2
FY 2016 Q4$18,106M; +1.6% vs FY 2016 Q3
FY 2017 Q1$17,766M; −1.9% vs FY 2016 Q4
FY 2017 Q2$18,839M; +6.0% vs FY 2017 Q1
FY 2017 Q3$19,650M; +4.3% vs FY 2017 Q2
FY 2017 Q4$20,195M; +2.8% vs FY 2017 Q3
FY 2018 Q1$20,009M; −0.9% vs FY 2017 Q4
FY 2018 Q2$20,830M; +4.1% vs FY 2018 Q1
FY 2018 Q3$20,348M; −2.3% vs FY 2018 Q2
FY 2018 Q4$20,394M; +0.2% vs FY 2018 Q3
FY 2019 Q1$20,021M; −1.8% vs FY 2018 Q4
FY 2019 Q2$20,562M; +2.7% vs FY 2019 Q1
FY 2019 Q3$20,729M; +0.8% vs FY 2019 Q2
FY 2019 Q4$20,747M; +0.1% vs FY 2019 Q3
FY 2020 Q1$20,691M; −0.3% vs FY 2019 Q4
FY 2020 Q2$18,336M; −11.4% vs FY 2020 Q1
FY 2020 Q3$21,082M; +15.0% vs FY 2020 Q2
FY 2020 Q4$22,475M; +6.6% vs FY 2020 Q3
FY 2021 Q1$22,321M; −0.7% vs FY 2020 Q4
FY 2021 Q2$23,312M; +4.4% vs FY 2021 Q1
FY 2021 Q3$23,338M; +0.1% vs FY 2021 Q2
FY 2021 Q4$24,804M; +6.3% vs FY 2021 Q3
FY 2022 Q1$23,426M; −5.6% vs FY 2021 Q4
FY 2022 Q2$24,020M; +2.5% vs FY 2022 Q1
FY 2022 Q3$23,791M; −1.0% vs FY 2022 Q2
FY 2022 Q4$19,939M; −16.2% vs FY 2022 Q3
FY 2023 Q1$24,746M; +24.1% vs FY 2022 Q4
FY 2023 Q2$25,530M; +3.2% vs FY 2023 Q1
FY 2023 Q3$21,351M; −16.4% vs FY 2023 Q2
FY 2023 Q4$21,395M; +0.2% vs FY 2023 Q3
FY 2024 Q1$21,383M; −0.1% vs FY 2023 Q4
FY 2024 Q2$22,447M; +5.0% vs FY 2024 Q1
FY 2024 Q3$22,471M; +0.1% vs FY 2024 Q2
FY 2024 Q4$22,520M; +0.2% vs FY 2024 Q3
FY 2025 Q1$21,893M; −2.8% vs FY 2024 Q4
FY 2025 Q2$23,743M; +8.5% vs FY 2025 Q1
FY 2025 Q3$23,993M; +1.1% vs FY 2025 Q2
FY 2025 Q4$24,564M; +2.4% vs FY 2025 Q3
FY 2026 Q1$24,062M; −2.0% vs FY 2025 Q4
FY 2026 Q2$25,310M; +5.2% vs FY 2026 Q1
Jun 28, 2009 through Sep 25, 2026

Free cash flow

USD millions

$7,295M
Johnson & Johnson Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2009 Q2$2,796M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$4,575M; +63.6% vs FY 2009 Q2
FY 2009 Q4$4,443M; −2.9% vs FY 2009 Q3
FY 2010 Q1$3,293M; −25.9% vs FY 2009 Q4
FY 2010 Q2$3,337M; +1.3% vs FY 2010 Q1
FY 2010 Q3$4,506M; +35.0% vs FY 2010 Q2
FY 2010 Q4$2,865M; −36.4% vs FY 2010 Q3
FY 2011 Q1$1,880M; −34.4% vs FY 2010 Q4
FY 2011 Q2$3,291M; +75.1% vs FY 2011 Q1
FY 2011 Q3$3,911M; +18.8% vs FY 2011 Q2
FY 2011 Q4$2,323M; −40.6% vs FY 2011 Q3
FY 2012 Q1$2,293M; −1.3% vs FY 2011 Q4
FY 2012 Q2$4,130M; +80.1% vs FY 2012 Q1
FY 2012 Q3$3,815M; −7.6% vs FY 2012 Q2
FY 2012 Q4$2,224M; −41.7% vs FY 2012 Q3
FY 2013 Q1$1,691M; −24.0% vs FY 2012 Q4
FY 2013 Q2$4,280M; +153.1% vs FY 2013 Q1
FY 2013 Q3$5,138M; +20.0% vs FY 2013 Q2
FY 2013 Q4$2,710M; −47.3% vs FY 2013 Q3
FY 2014 Q1$3,293M; +21.5% vs FY 2013 Q4
FY 2014 Q2$4,692M; +42.5% vs FY 2014 Q1
FY 2014 Q3$3,903M; −16.8% vs FY 2014 Q2
FY 2014 Q4$2,869M; −26.5% vs FY 2014 Q3
FY 2015 Q1$2,329M; −18.8% vs FY 2014 Q4
FY 2015 Q2$4,435M; +90.4% vs FY 2015 Q1
FY 2015 Q3$5,336M; +20.3% vs FY 2015 Q2
FY 2015 Q4$3,716M; −30.4% vs FY 2015 Q3
FY 2016 Q1$1,124M; −69.8% vs FY 2015 Q4
FY 2016 Q2$4,233M; +276.6% vs FY 2016 Q1
FY 2016 Q3$4,624M; +9.2% vs FY 2016 Q2
FY 2016 Q4$5,560M; +20.2% vs FY 2016 Q3
FY 2017 Q1$2,353M; −57.7% vs FY 2016 Q4
FY 2017 Q2$5,083M; +116.0% vs FY 2017 Q1
FY 2017 Q3$5,476M; +7.7% vs FY 2017 Q2
FY 2017 Q4$4,865M; −11.2% vs FY 2017 Q3
FY 2018 Q1$2,948M; −39.4% vs FY 2017 Q4
FY 2018 Q2$5,204M; +76.5% vs FY 2018 Q1
FY 2018 Q3$5,453M; +4.8% vs FY 2018 Q2
FY 2018 Q4$4,926M; −9.7% vs FY 2018 Q3
FY 2019 Q1$2,887M; −41.4% vs FY 2018 Q4
FY 2019 Q2$5,111M; +77.0% vs FY 2019 Q1
FY 2019 Q3$6,782M; +32.7% vs FY 2019 Q2
FY 2019 Q4$5,138M; −24.2% vs FY 2019 Q3
FY 2020 Q1$2,733M; −46.8% vs FY 2019 Q4
FY 2020 Q2$2,790M; +2.1% vs FY 2020 Q1
FY 2020 Q3$7,646M; +174.1% vs FY 2020 Q2
FY 2020 Q4$7,020M; −8.2% vs FY 2020 Q3
FY 2021 Q1$3,397M; −51.6% vs FY 2020 Q4
FY 2021 Q2$4,501M; +32.5% vs FY 2021 Q1
FY 2021 Q3$7,543M; +67.6% vs FY 2021 Q2
FY 2021 Q4$4,317M; −42.8% vs FY 2021 Q3
FY 2022 Q1$3,372M; −21.9% vs FY 2021 Q4
FY 2022 Q2$4,718M; +39.9% vs FY 2022 Q1
FY 2022 Q3$5,332M; +13.0% vs FY 2022 Q2
FY 2022 Q4$3,763M; −29.4% vs FY 2022 Q3
FY 2023 Q1$2,394M; −36.4% vs FY 2022 Q4
FY 2023 Q2$3,058M; +27.7% vs FY 2023 Q1
FY 2023 Q3$6,522M; +113.3% vs FY 2023 Q2
FY 2023 Q4$6,274M; −3.8% vs FY 2023 Q3
FY 2024 Q1$2,850M; −54.6% vs FY 2023 Q4
FY 2024 Q2$4,657M; +63.4% vs FY 2024 Q1
FY 2024 Q3$6,964M; +49.5% vs FY 2024 Q2
FY 2024 Q4$5,371M; −22.9% vs FY 2024 Q3
FY 2025 Q1$3,379M; −37.1% vs FY 2024 Q4
FY 2025 Q2$2,835M; −16.1% vs FY 2025 Q1
FY 2025 Q3$8,012M; +182.6% vs FY 2025 Q2
FY 2025 Q4$5,472M; −31.7% vs FY 2025 Q3
FY 2026 Q1$1,465M; −73.2% vs FY 2025 Q4
FY 2026 Q2$7,295M; +398.0% vs FY 2026 Q1

Net margin

%

21.86%
Johnson & Johnson Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q221.05%
FY 2009 Q322.18%
FY 2009 Q413.33%
FY 2010 Q128.96%
FY 2010 Q222.5%
FY 2010 Q322.81%
FY 2010 Q412.41%
FY 2011 Q121.49%
FY 2011 Q216.73%
FY 2011 Q320.01%
FY 2011 Q41.34%
FY 2012 Q124.23%
FY 2012 Q28.55%
FY 2012 Q317.41%
FY 2012 Q414.62%
FY 2013 Q119.98%
FY 2013 Q221.44%
FY 2013 Q316.97%
FY 2013 Q419.17%
FY 2014 Q126.09%
FY 2014 Q222.19%
FY 2014 Q325.72%
FY 2014 Q413.81%
FY 2015 Q124.86%
FY 2015 Q225.39%
FY 2015 Q319.64%
FY 2015 Q418.05%
FY 2016 Q124.55%
FY 2016 Q221.63%
FY 2016 Q323.97%
FY 2016 Q421.06%
FY 2017 Q124.89%
FY 2017 Q220.31%
FY 2017 Q319.16%
FY 2017 Q4-53.05%
FY 2018 Q121.83%
FY 2018 Q218.98%
FY 2018 Q319.33%
FY 2018 Q414.92%
FY 2019 Q118.73%
FY 2019 Q227.27%
FY 2019 Q38.46%
FY 2019 Q419.33%
FY 2020 Q128.01%
FY 2020 Q219.78%
FY 2020 Q316.86%
FY 2020 Q47.73%
FY 2021 Q127.76%
FY 2021 Q226.93%
FY 2021 Q315.71%
FY 2021 Q419.09%
FY 2022 Q121.98%
FY 2022 Q220.04%
FY 2022 Q318.74%
FY 2022 Q417.65%
FY 2023 Q1-0.27%
FY 2023 Q220.15%
FY 2023 Q3121.91%
FY 2023 Q418.92%
FY 2024 Q115.22%
FY 2024 Q220.88%
FY 2024 Q311.99%
FY 2024 Q415.24%
FY 2025 Q150.24%
FY 2025 Q223.32%
FY 2025 Q321.47%
FY 2025 Q420.83%
FY 2026 Q121.76%
FY 2026 Q221.86%

P/E

× · TTM · Daily

31.46×
Johnson & Johnson P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2012-02-2913.34×2010-10-03
2012-03-3013.52×2010-10-03
2012-04-3013.34×2010-10-03
2012-05-3112.79×2010-10-03
2012-06-2913.84×2010-10-03
2012-07-3114.18×2010-10-03
2012-08-3113.82×2010-10-03
2012-09-2814.12×2010-10-03
2012-10-3114.51×2010-10-03
2012-11-3014.29×2010-10-03
2012-12-3114.36×2010-10-03
2013-01-3115.15×2010-10-03
2013-02-2819.88×2012-12-30
2013-03-2821.3×2012-12-30
2013-04-3022.27×2012-12-30
2013-05-3121.99×2012-12-30
2013-06-2822.43×2012-12-30
2013-07-3124.43×2012-12-30
2013-08-3022.58×2012-12-30
2013-09-3022.65×2012-12-30
2013-10-3124.19×2012-12-30
2013-11-2921.18×2013-09-29
2013-12-3120.49×2013-09-29
2014-01-3119.79×2013-09-29
2014-02-2819.12×2013-12-29
2014-03-3120.39×2013-12-29
2014-04-3021.03×2013-12-29
2014-05-3019.37×2014-03-30
2014-06-3019.97×2014-03-30
2014-07-3119.1×2014-03-30
2014-08-2919.17×2014-06-29
2014-09-3019.7×2014-06-29
2014-10-3117.82×2014-09-28
2014-11-2817.9×2014-09-28
2014-12-3117.29×2014-09-28
2015-01-3016.56×2014-09-28
2015-02-2717.85×2014-12-28
2015-03-3117.52×2014-12-28
2015-04-3017.27×2014-12-28
2015-05-2917.78×2015-03-29
2015-06-3017.3×2015-03-29
2015-07-3117.79×2015-03-29
2015-08-3116.41×2015-06-28
2015-09-3016.3×2015-06-28
2015-10-3017.64×2015-06-28
2015-11-3019.31×2015-09-27
2015-12-3119.6×2015-09-27
2016-01-2919.92×2015-09-27
2016-02-2919.13×2016-01-03
2016-03-3119.67×2016-01-03
2016-04-2920.38×2016-01-03
2016-05-3120.48×2016-04-03
2016-06-3022.05×2016-04-03
2016-07-2922.76×2016-04-03
2016-08-3122.44×2016-07-03
2016-09-3022.21×2016-07-03
2016-10-3121.81×2016-07-03
2016-11-3019.65×2016-10-02
2016-12-3020.34×2016-10-02
2017-01-3120×2016-10-02
2017-02-2820.44×2017-01-01
2017-03-3120.83×2017-01-01
2017-04-2820.65×2017-01-01
2017-05-3121.4×2017-04-02
2017-06-3022.08×2017-04-02
2017-07-3122.15×2017-04-02
2017-08-3122.22×2017-07-02
2017-09-2921.82×2017-07-02
2017-10-3123.4×2017-07-02
2017-11-3024.1×2017-10-01
2017-12-2924.17×2017-10-01
2018-01-3123.9×2017-10-01
2018-02-28273.95×2017-12-31
2018-03-29270.3×2017-12-31
2018-04-30266.8×2017-12-31
2018-05-31262.48×2018-04-01
2018-06-29266.26×2018-04-01
2018-07-31290.79×2018-04-01
2018-08-31295.55×2018-04-01
2018-09-28303.19×2018-04-01
2018-10-31307.18×2018-04-01
2018-11-30322.34×2018-04-01
2018-12-31283.17×2018-04-01
2019-01-31292.02×2018-04-01
2019-02-2824.35×2018-12-30
2019-03-2924.91×2018-12-30
2019-04-3025.16×2018-12-30
2019-05-3123.37×2018-12-30
2019-06-2824.82×2018-12-30
2019-07-3123.21×2018-12-30
2019-08-3022.87×2018-12-30
2019-09-3023.06×2018-12-30
2019-10-3124.91×2019-09-29
2019-11-2925.94×2019-09-29
2019-12-3127.52×2019-09-29
2020-01-3128.09×2019-09-29
2020-02-2823.77×2019-12-29
2020-03-3123.18×2019-12-29
2020-04-3023.35×2020-03-29
2020-05-2923.15×2020-03-29
2020-06-3021.88×2020-03-29
2020-07-3125.59×2020-06-28
2020-08-3126.93×2020-06-28
2020-09-3026.13×2020-06-28
2020-10-3021.55×2020-09-27
2020-11-3022.74×2020-09-27
2020-12-3124.73×2020-09-27
2021-01-2925.64×2020-09-27
2021-02-2624.9×2020-09-27
2021-03-3125.83×2020-09-27
2021-04-3025.57×2020-09-27
2021-05-2829.93×2021-04-04
2021-06-3029.13×2021-04-04
2021-07-3025.89×2021-07-04
2021-08-3126.03×2021-07-04
2021-09-3024.28×2021-07-04
2021-10-2924.49×2021-07-04
2021-11-3023.33×2021-10-03
2021-12-3125.59×2021-10-03
2022-01-3125.78×2021-10-03
2022-02-2821.06×2022-01-02
2022-03-3122.68×2022-01-02
2022-04-2923.1×2022-01-02
2022-05-3124.14×2022-04-03
2022-06-3023.87×2022-04-03
2022-07-2923.47×2022-04-03
2022-08-3123.44×2022-07-03
2022-09-3023.73×2022-07-03
2022-10-3124.17×2022-10-02
2022-11-3024.73×2022-10-02
2022-12-3024.54×2022-10-02
2023-01-3122.7×2022-10-02
2023-02-2821.29×2022-10-02
2023-03-3121.53×2022-10-02
2023-04-2822.74×2022-10-02
2023-05-3121.54×2022-10-02
2023-06-3022.99×2022-10-02
2023-07-3123.27×2022-10-02
2023-08-3122.46×2022-10-02
2023-09-2921.64×2022-10-02
2023-10-3121.94×2023-01-01
2023-11-3022.87×2023-01-01
2023-12-2923.18×2023-01-01
2024-01-3123.5×2023-01-01
2024-02-2911.88×2023-10-01
2024-03-2811.65×2023-10-01
2024-04-3010.65×2023-10-01
2024-05-319.26×2024-03-31
2024-06-289.23×2024-03-31
2024-07-3110.06×2024-06-30
2024-08-3010.57×2024-06-30
2024-09-3010.32×2024-06-30
2024-10-3126.43×2024-09-29
2024-11-2925.63×2024-09-29
2024-12-3123.91×2024-09-29
2025-01-3125.16×2024-09-29
2025-02-2827.28×2024-09-29
2025-03-3127.42×2024-09-29
2025-04-3017.37×2025-03-30
2025-05-3017.25×2025-03-30
2025-06-3016.98×2025-03-30
2025-07-3117.59×2025-06-29
2025-08-2918.91×2025-06-29
2025-09-3019.79×2025-06-29
2025-10-3118.26×2025-09-28
2025-11-2820.01×2025-09-28
2025-12-3120.01×2025-09-28
2026-01-3021.97×2025-09-28
2026-02-2724.02×2025-09-28
2026-03-3123.63×2025-09-28
2026-04-3026.71×2026-03-29
2026-05-2926.19×2026-03-29
2026-06-3029.52×2026-03-29
2026-07-3129.73×2026-06-28
2026-08-3130.84×2026-06-28
2026-09-2531.46×2026-06-28

ROIC

% · Annual / TTM

—
Johnson & Johnson ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q2—
FY 2010 Q3—
FY 2010 Q426.95%
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q420.29%
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q419.3%
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q421.35%
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q423.59%
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q4—
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q4—
FY 2018 Q1—
FY 2018 Q2—
FY 2018 Q3—
FY 2018 Q4—
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q4—
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q4—
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q4—
FY 2022 Q1—
FY 2022 Q2—
FY 2022 Q3—
FY 2022 Q4—
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$1,542M
Johnson & Johnson capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q265.7% · $567M0% · $0M33.49% · $289MUnavailable0.81% · $7M100% · $863M
FY 2009 Q328.49% · $519M57.41% · $1,046M2.69% · $49MUnavailable11.42% · $208M100% · $1,822M
FY 2009 Q443.62% · $844M6.87% · $133M49.51% · $958MUnavailableUnavailable100% · $1,935M
FY 2010 Q125.45% · $397M49.49% · $772M24.55% · $383MUnavailable0.51% · $8M100% · $1,560M
FY 2010 Q250% · $500M9.9% · $99M39.7% · $397MUnavailable0.4% · $4M100% · $1,000M
FY 2010 Q331.67% · $528M23.88% · $398M43.91% · $732MUnavailable0.54% · $9M100% · $1,667M
FY 2010 Q442.53% · $959M0% · $0M56.98% · $1,285MUnavailable0.49% · $11M100% · $2,255M
FY 2011 Q114.92% · $436M70.1% · $2,049M14.88% · $435MUnavailable0.1% · $3M100% · $2,923M
FY 2011 Q255.48% · $618M0% · $0M44.34% · $494MUnavailable0.18% · $2M100% · $1,114M
FY 2011 Q337.8% · $711M22.33% · $420M39.5% · $743MUnavailable0.37% · $7M100% · $1,881M
FY 2011 Q448.77% · $1,128M14.18% · $328M36.88% · $853MUnavailable0.17% · $4M100% · $2,313M
FY 2012 Q183.81% · $502M0% · $0M11.19% · $67MUnavailable5.01% · $30M100% · $599M
FY 2012 Q21.92% · $598M56.76% · $17,659M41.31% · $12,852MUnavailableUnavailable100% · $31,109M
FY 2012 Q346.46% · $682MUnavailable0% · $0MUnavailable53.54% · $786M100% · $1,468M
FY 2012 Q494.19% · $1,152M5.15% · $63M0% · $0MUnavailable0.65% · $8M100% · $1,223M
FY 2013 Q177.62% · $586M22.25% · $168M0% · $0MUnavailable0.13% · $1M100% · $755M
FY 2013 Q233.82% · $771M0.26% · $6M0% · $0MUnavailable65.92% · $1,503M100% · $2,280M
FY 2013 Q317.85% · $809M14.24% · $645M67.31% · $3,050MUnavailable0.6% · $27M100% · $4,531M
FY 2013 Q471.63% · $1,429M0.8% · $16M24.46% · $488MUnavailable3.11% · $62M100% · $1,995M
FY 2014 Q144.21% · $630M0% · $0M54.32% · $774MUnavailable1.47% · $21M100% · $1,425M
FY 2014 Q222.11% · $837M0% · $0M31.49% · $1,192MUnavailable46.39% · $1,756M100% · $3,785M
FY 2014 Q321.66% · $751M8.39% · $291M69.66% · $2,415MUnavailable0.29% · $10M100% · $3,467M
FY 2014 Q424.39% · $1,496M29.96% · $1,838M44.72% · $2,743MUnavailable0.93% · $57M100% · $6,134M
FY 2015 Q118.16% · $543M7.79% · $233M73.51% · $2,198MUnavailable0.54% · $16M100% · $2,990M
FY 2015 Q245.92% · $765M0% · $0M53.78% · $896MUnavailable0.3% · $5M100% · $1,666M
FY 2015 Q372.05% · $789M0% · $0M27.4% · $300MUnavailable0.55% · $6M100% · $1,095M
FY 2015 Q433.95% · $1,366M17.92% · $721M47.12% · $1,896MUnavailable1.02% · $41M100% · $4,024M
FY 2016 Q120.97% · $639M0.16% · $5M78.4% · $2,389MUnavailable0.46% · $14M100% · $3,047M
FY 2016 Q215.88% · $757M15.21% · $725M49.56% · $2,362MUnavailable19.35% · $922M100% · $4,766M
FY 2016 Q311.74% · $737M52.89% · $3,320M35.1% · $2,203MUnavailable0.27% · $17M100% · $6,277M
FY 2016 Q422.55% · $1,093M9.47% · $459M41.78% · $2,025MUnavailable26.2% · $1,270M100% · $4,847M
FY 2017 Q16.4% · $560M55.41% · $4,852M38.17% · $3,342MUnavailable0.02% · $2M100% · $8,756M
FY 2017 Q22.17% · $689M91.85% · $29,220M5.94% · $1,890MUnavailable0.04% · $13M100% · $31,812M
FY 2017 Q329.43% · $790M21.39% · $574M11.59% · $311MUnavailable37.59% · $1,009M100% · $2,684M
FY 2017 Q437.43% · $1,240M15.24% · $505M24.6% · $815MUnavailable22.73% · $753M100% · $3,313M
FY 2018 Q130.02% · $658M3.74% · $82M65.88% · $1,444MUnavailable0.36% · $8M100% · $2,192M
FY 2018 Q275.37% · $875M12.06% · $140M12.49% · $145MUnavailable0.09% · $1M100% · $1,161M
FY 2018 Q328.58% · $819M23.55% · $675M16.43% · $471MUnavailable31.44% · $901M100% · $2,866M
FY 2018 Q422.83% · $1,318M0.03% · $2M65.96% · $3,808MUnavailable11.17% · $645M100% · $5,773M
FY 2019 Q111.83% · $656M30.34% · $1,683M39.77% · $2,206MUnavailable18.06% · $1,002M100% · $5,547M
FY 2019 Q211.98% · $837M52.41% · $3,663M35.57% · $2,486MUnavailable0.04% · $3M100% · $6,989M
FY 2019 Q328.74% · $745M8.33% · $216M62.81% · $1,628MUnavailable0.12% · $3M100% · $2,592M
FY 2019 Q433.61% · $1,260M6.62% · $248M11.36% · $426MUnavailable48.41% · $1,815M100% · $3,749M
FY 2020 Q119.02% · $625M28.58% · $939M52.07% · $1,711MUnavailable0.33% · $11M100% · $3,286M
FY 2020 Q248.04% · $662M0.73% · $10M51.23% · $706MUnavailable0% · $0M100% · $1,378M
FY 2020 Q341.61% · $737M0% · $0M27.27% · $483MUnavailable31.11% · $551M100% · $1,771M
FY 2020 Q415.53% · $1,323M74.81% · $6,374M3.77% · $321MUnavailable5.89% · $502M100% · $8,520M
FY 2021 Q121.73% · $677M0% · $0M46.15% · $1,438MUnavailable32.12% · $1,001M100% · $3,116M
FY 2021 Q242.93% · $813M0% · $0M33.32% · $631MUnavailable23.76% · $450M100% · $1,894M
FY 2021 Q365.58% · $747M0% · $0M34.33% · $391MUnavailable0.09% · $1M100% · $1,139M
FY 2021 Q450.16% · $1,415M2.13% · $60M35.31% · $996MUnavailable12.41% · $350M100% · $2,821M
FY 2022 Q113.29% · $607M5.52% · $252M34.52% · $1,577MUnavailable46.67% · $2,132M100% · $4,568M
FY 2022 Q240.96% · $863M12.86% · $271M46.18% · $973MUnavailable0% · $0M100% · $2,107M
FY 2022 Q330.53% · $952MUnavailable69.44% · $2,165MUnavailable0.03% · $1M100% · $3,118M
FY 2022 Q47.92% · $1,587M85.49% · $17,130M6.59% · $1,320MUnavailable0% · $1M100% · $20,038M
FY 2023 Q117.61% · $863M0% · $0M72.18% · $3,537MUnavailable10.2% · $500M100% · $4,900M
FY 2023 Q274.63% · $1,124M0% · $0M25.3% · $381MUnavailable0.07% · $1M100% · $1,506M
FY 2023 Q351.22% · $967M0% · $0M48.73% · $920MUnavailable0.05% · $1M100% · $1,888M
FY 2023 Q455.68% · $1,589M0% · $0M7.57% · $216MUnavailable36.76% · $1,049M100% · $2,854M
FY 2024 Q119.71% · $807M44.24% · $1,811M36.03% · $1,475MUnavailable0.02% · $1M100% · $4,094M
FY 2024 Q26.92% · $976M92.12% · $12,996M0.96% · $136MUnavailableUnavailable100% · $14,108M
FY 2024 Q353.99% · $1,029M17.73% · $338M28.28% · $539MUnavailableUnavailable100% · $1,906M
FY 2024 Q485.07% · $1,612M0.05% · $1M14.88% · $282MUnavailableUnavailable100% · $1,895M
FY 2025 Q127.21% · $795M0% · $0M72.79% · $2,127MUnavailableUnavailable100% · $2,922M
FY 2025 Q26.73% · $1,043M93.27% · $14,458M0% · $0MUnavailableUnavailable100% · $15,501M
FY 2025 Q337.81% · $1,157M0.03% · $1M62.16% · $1,902MUnavailableUnavailable100% · $3,060M
FY 2025 Q427.01% · $1,837M44.71% · $3,041M28.29% · $1,924MUnavailableUnavailable100% · $6,802M
FY 2026 Q14.65% · $1,049M77.51% · $17,500M17.84% · $4,028MUnavailableUnavailable100% · $22,577M
FY 2026 Q285.67% · $1,321MUnavailable14.33% · $221MUnavailableUnavailable100% · $1,542M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Johnson & Johnson.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources